アイラト株式会社

Airato specializes in the development of radiation therapy using artificial intelligence technology.

アイラト株式会社 is active in the artificial intelligence (ai), manufacturing, medical, therapeutics space based in Asia-Pacific (APAC), founded in 2022.

Profile

"Airato is a pioneering Medtech company focused on developing cutting-edge radiation therapy solutions using artificial intelligence technology. Specializing in IMRT, a state-of-the-art radiation therapy that enhances the quality of life for cancer patients, Airato's flagship product, AIVOT, is an AI-powered solution trained on high-quality data from leading medical centers in Japan. AIVOT automates various processes using AI, enabling the creation of high-quality treatment plans with precise predictive technology. By establishing safety and efficiency in treatment planning, AIVOT contributes to building a more stable healthcare system while reducing the burden on medical staff. This not only leads to cost savings in labor but also enhances revenue opportunities through improved medical services."

Its activity falls under artificial intelligence (ai), manufacturing, medical, therapeutics; the profile below is assembled from public directory data.

The business is associated with Asia-Pacific (APAC).

Its current recorded stage is Seed.

Public records show total funding of about $80M.

Website: airato.jp